Ensuring Integrity in Scientific Publications in the face of AI

This podcast is a recording of a live #MedComms webinar.

Instances of peer-reviewed publications now appearing in their final published form with obvious AI prompts still included in the text, have sparked lively social media discussion about the basic integrity of the scientific publications process. Is it in fact fit for purpose? In this webinar, we will talk about the practicalities involved in publishing a peer-review paper and who is involved in what steps. We'll discuss how AI tools are already being used by authors, other contributors, peer-reviewers and the production teams themselves. We'll highlight the pitfalls and we'll think about how these tools can be built into the process while maintaining the high level of trust in the integrity of scientific publishing that is so important for everyone. On our panel we will be joined by Laura Dormer (Becaris Publishing), Hamish McDougall (SAGE Publishing) and Jonathan Patience (Taylor and Francis). And we answer questions from the audience.

It should be of interest to anyone who is working in and around MedComms, or who is wanting to join the business. 

Recorded 22 May 2024 as a MedComms Networking webinar. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Laura's LinkedIn page is at https://www.linkedin.com/in/lauradormer/

Find out more about Becaris Publishing at https://becaris.com/

Hamish's LinkedIn page is at https://www.linkedin.com/in/hamish-mcdougall-73398764/

Find out more about SAGE Publishing at http://www.sagepub.co.uk/

Jonathan's LinkedIn page is at https://www.linkedin.com/in/jonathan-patience-679b1224/

Find out more about Taylor and Francis at http://taylorandfrancis.com/

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free webcasts and other video content for the global MedComms Community and others at https://networkpharma.tv and we'd welcome your suggestions for new content.